The Recall Desk
SevereFDA (Drugs)·D-0314-2015·Announced 2014-12-31

Chaotic Labz Recalls MAYHEM Capsules Containing Undeclared Prescription Drugs

Chaotic Labz is recalling MAYHEM capsules because FDA analysis found undeclared dexamethasone and cyproheptadine, making the product an unapproved drug.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for significant health risks involving unapproved drugs.

Plain-English summary

Chaotic Labz is recalling 990 bottles of MAYHEM capsules, Proprietary Blend 525 mg, Dietary Supplement, 60-count bottles. The affected product is identified by Lot number CLM061114 and expiration date 06/16. The product was distributed nationwide.

The recall was initiated because FDA analysis found that the product contains undeclared dexamethasone and cyproheptadine. These are FDA-approved drugs, which makes the product an unapproved drug marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).

Consumers who have purchased this product should stop using it and contact Chaotic Labz for further instructions.

The recalled product

Product
MAYHEM capsules, Proprietary Blend 525 mg, Dietary Supplement, 60-count bottles, Chaotic-Labz, UPC 6 28586 67805 7.
Manufacturer
Chaotic Labz
Category
Drug — Dietary Supplement
Hazard
Affected units
990

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot#: CLM061114
  • Exp 06/16

Distribution

Distributed nationwide across the United States.

Related recalls

Same hazard · undeclared drug

See all →